Charlotte's Web Reports 2023 Second Quarter Financial Results
Retrieved on:
星期四, 八月 10, 2023
Coalition, CWEB, Sportsmen's Heritage And Recreational Enhancement Act of 2013, Congress, Natural American Spirit, Toxicology, Sport, American Legion, Press release, House, American Tobacco Company, NYSE, Interstate Commerce Committee, Nielsen Holdings, The Vitamin Shoppe, Auckland CBD, PBC, Human, Ethics committee, ACV, Hearing, TSX, Growth, FDA, IND, Safety, Legislation, LSE, Request, Energy, Millennials, Access, BTI, Charlotte's Web, Partnership, Stark Industries, Financial services, All, Clinical trial, Cannabinoid, Ethics, Premier Lacrosse League, Richard Genzer, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Pharmaceutical industry, Dietary supplement, Online shopping, CBD, Operation
Net revenue of $16.0M vs. $18.9M YoY
Key Points:
- Net revenue of $16.0M vs. $18.9M YoY
LOUISVILLE, Colo., Aug. 10, 2023 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2023. - During the second quarter, the U.S. Food and Drug Administration ("FDA") committed to "work at speed" with Congress to resolve a regulatory pathway for hemp-derived CBD.
- Recent progress has been encouraging surrounding The Hemp Derived Consumer Protection and Market Stabilization Act of 2023, (bill H.R.
- Charlotte's Web and industry peers have compiled and shared safety and toxicology data with Congress to address concerns raised by the FDA.